![Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial - The Lancet Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial - The Lancet](https://www.thelancet.com/cms/attachment/f3fde9e5-2c1a-491f-bad9-c7fad0a0a04a/gr1.gif)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial - The Lancet
![Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 - Kushner - 2020 - Obesity - Wiley Online Library Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 - Kushner - 2020 - Obesity - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e53cce3c-7ed2-4170-9374-99b97a5c06e8/oby22794-fig-0006-m.jpg)
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5 - Kushner - 2020 - Obesity - Wiley Online Library
![PDF] Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial | Semantic Scholar PDF] Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7fe85daed4f884830ea71a1fe88205a43e1c1a7f/4-Table1-1.png)